Improves Ventilation in COPD1
After Baseline care plus Aerobika* device
Before Baseline care
Yellow circles represent areas of greatest change after 3-4 weeks of Aerobika* device use.
Improves Quality of Life
Responder rates for improvements greater than the MCID2
Improvement
Study 1
†
Improvement
Study 2‡
0
20
SGRQ = St. George’s Respiratory
Questionnaire;
CAT = COPD Assessment Test
† Randomized, cross-over study
evaluating the efficacy of the
Aerobika* device after 3-4 weeks
of treatment in patients with COPD
and chronic bronchitis.
‡ Clinical assessment of patients
with COPD and chronic bronchitis
over 8 weeks of treatment with the
Aerobika* device.
62%
8 weeks
in CAT
≥2 point
(n=26)
64%
3-4 weeks
in SGRQ
≥4 point
(n=14)
40
60
80
Percent of patients (%)
Reduces COPD Exacerbations by 28%
in the critical 30 day period3
Trudell Medical International
15
28
reduction
10
p=0.014
%
20
5
0
Control cohort
(n=405)
Aerobika* device cohort
(n=405)
Improves lung function in COPD4
3200
3100
200
mL
improvement
+
3000
FVC (mL)
Aerobika* OPEP Device
Percent of patients (%)
25
2900
in FVC
2800
p=0.005
2700
2600
0
pre-Aerobika* device use
post-Aerobika* device use